News & Analysis on Clinical Trial Services & Contract Research And Development
People on the move: outsourcing jobs
By Natalie Morrison
- Last updated on
Creabilis has expanded its senior management team with the appointment of three international pharma executives; Alex Leech, James Sandy and Peter Spargo.
Leech, who will join the team as VP, head of finance and operations was most recently head of operations at Solace Pharmaceuticals.
Former Pfizer development team leader Sandy has over 25 years of pharmaceutical development R&D experience. He will take on the role of senior VP, head of development at Creabilis.
And Spargo, who prior to Creabilis was at Novexel as senior VP of chemistry manufacturing and controls (CMC), will become senior VP for CMC.
Of their new appointments, Eliot Forster CEO of Creabilis said: "This expansion of our senior management team to complement our current team, reflects Creabilis' growing maturity and the confidence we have in our pipeline, our science and the culture that underpins it.”
Mahmoud Ghazzi has joined Daiichi Sankyo Pharma Development (DSPD) as its new executive vice president of drug development for the Americas region.
Ghazzi comes to the business from various positions at GlaxoSmithKline (GSK) and Pfizer where he developed and managed clinical trials for cardiovascular, metabolism, obesity and diabetes drugs.
"In today's pharmaceutical landscape, success hinges on quality, clinical excellence and ultimately developing innovative medicines that offer patients greater clinical benefit over existing therapies," said Dr. Ghazzi. "I am happy to be part of an organization that continues to sharpen its focus in these areas and that continues to develop products that address significant health issues for illnesses such as cardiovascular disease, infections disease and cancer."
Pharmaceutical wholesalers H. D. Smith has named David Guzman chief information officer.
Guzman – previously chief information officer for a number of technology, healthcare and retail giants – will be responsible for developing and applying information technology initiatives across H. D. Smith's supply-chain and cost-management systems.
Dale Smith, chairman and CEO, at H.D.Smith said: "Health information technology is critical to community healthcare and essential to any retail or institutional setting, providing the innovative tools that allow pharmacists to ensure a medicine is on hand and costs are closely watched.”
Healthcare communications agency Virgo Health has appointed Rebecca Neil as senior account manager.
Neil spent six years at the GlaxoSmithKline, where she held a number of senior roles in areas such as regulatory affairs and global medical affairs.
At Virgo, she will be responsible for managing delivery of medical education programs for clients including Takeda and Novartis.
Of her new role, she said: “I look forward to working for a real leader in medical communications, where creative and innovative strategies are at the core of the business without comprising compliance and quality.”
Philip Eykerman has joined global life sciences and materials company Royal DSM.
Eykerman, who is currently a partner at McKinsey & Company Brussels, will take on the role of executive VP corporate strategy and acquisitions.
A spokesperson for the company said: “With his track record of strategy development and M & A strategy and integration, Philip is well positioned to lead DSM's corporate strategy and acquisition department and drive the development of DSM's strategic growth agenda.”
ERT have appointed patient reported outcomes (PRO) strategist Linda Deal to lead their health outcomes research initiative.
Deal comes to the technology CRO from her role as immunology PRO lead at Janssen Pharma – a division of Johnson & Johnson.
Jeffrey Litwin MD, president and CEO of ERT said: "Having worked inside sponsor organizations and across a number of entities within the PRO community, Linda brings insight and perspective on the creation and implementation of Patient, Clinician and Observer reported outcomes.
Her domain knowledge will enable her to add considerable value to ERT's offerings and to our clients."
ACM Global Central Lab has extended their management team with Suzanne Dale, Sara Diaz.
Dale, a former assistant professor at McMaster University in the Department of Pathology and Molecular Medicine, will become the laboratories’ new director of Microbiology.
And after working at Abington Memorial Hospital, where she was the core laboratory operations manager, Diaz will become ACM’s manager of Hematology.
“We are very pleased to welcome these highly qualified professionals to our medical team at ACM,” said Dr. Mary Williamson, director of laboratory operations at ACM.